Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
L
Lépine, Guylaine
Hôpital Maisonneuve-Rosemont
(
P 049
)
IMPLEMENTATION OF A ROUTINE DIAGNOSTIC NEXT GENERATION SEQUENCING PANEL OF FUSION-POSITIVE SARCOMAS: A SINGLE CENTER EXPERIENCE
Guylaine Lépine
Favorite
López-Gómez, Victoria
Department of Medical Oncology, Ramón y Cajal University Hospital
(
P 157
)
MOLECULAR SCREENING OF ADVANCED SARCOMAS THROUGH NEXT-GENERATION SEQUENCING IN A TERTIARY UNIVERSITY HOSPITAL
Victoria López-Gómez
Favorite
Laack, Nadia
Mayo Clinic
(
P 020
)
DEFINITIVE RADIATION THERAPY FOR EWING SARCOMA: TREATMENT AND TOXICITY OUTCOMES IN PATIENTS TREATED WITH DOSE ESCALATION APPROACHES
Nadia Laack
Favorite
(
P 023
)
FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS TREATED WITH SURGERY ON AEWS1031: A REPORT FROM THE CHILDRENS ONCOLOGY GROUP
Nadia Laack
Favorite
(
P 201
)
LOCAL CONTROL AND SURVIVAL OUTCOMES IN PEDIATRIC NON-RHABDOMYOSARCOMA SOFT TISSUE SARCOMA: THE MAYO CLINIC EXPERIENCE
Nadia Laack
Favorite
Labrecque, Maximilian
University of Calgary McCaig Bone and Joint Institute
(
P 142
)
USE OF SMALL MOLECULE STIMULATE OF TYPE-1 INTERFERON GENES (STING) AGONIST IMMUNOTHERAPY FOR CANINE SARCOMA: A CROSS-SPECIES ANALYSIS
Maximilian Labrecque
Favorite
Lacambra, Maribel
Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong
(
P 210
)
A LONGITUDINAL ANALYSIS OF PROGNOSTIC FACTORS IN CHINESE PATIENTS WITH RETROPERITONEAL LIPOSARCOMA
Maribel Lacambra
Favorite
Ladenstein, Ruth
Children's Cancer Research Institute, Paediatric Oncology, Vienna, Austria
(
P 040
)
TWO RARE SIDES OF ONE RARE DISEASE: EWING SARCOMA WITH AND AS SECONDARY MALIGNANCIES FROM THE EPIDEMIOLOGICAL AND CLINICAL ANALYSIS OF AN INTERNATIONAL TRIAL REGISTRY
Ruth Ladenstein
Favorite
Laeis, Petra
Daiichi Sankyo Europe GmbH, Munich, Germany
(
P 038
)
TENOSYNOVIAL GIANT CELL TUMOR OBSERVATIONAL PLATFORM PROJECT (TOPP): 2-YEAR OBSERVATIONAL SUB-ANALYSIS OF AGE AND PATIENT-REPORTED OUTCOMES FROM AN EU/US PROSPECTIVE REGISTRY
Petra Laeis
Favorite
Laetsch, Theodore
The Children’s Hospital of Philadelphia, University of Pennsylvania
(
P 323
)
PHASE 2 STUDY TO EVALUATE PALBOCICLIB (IBRANCE®) IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY EWING SARCOMA.
Theodore Laetsch
Favorite
Laffi, Alice
Medical Oncology and Hematology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089, Italy
(
P 02
)
CLINICAL CHARACTERISTICS AND OUTCOME OF ADOLESCENT AND YOUNG ADULTS SOFT TISSUE AND BONE SARCOMAS AT AN ADULT CANCER CENTER: THE BENEFITS OF A DEDICATED, MULTIDISCIPLINARY MANAGEMENT
Alice Laffi
Favorite
(
P 08
)
HOW TO DEVELOP AN ADOLESCENT AND YOUNG PROGRAM IN AN ADULT CANCER CENTER: THE HUMANITAS RESEARCH HOSPITAL EXPERIENCE
Alice Laffi
Favorite
Laffi, Alice
Humanitas Research Hospital
(
P 057
)
SARCOMA MICROENVIRONMENT CHARACTERIZATION: CLINICOPATHOLOGICAL ANALYSIS OF ONE-HUNDRED TWENTY-SIX CASES
Alice Laffi
Favorite
(
P 106
)
LAPAROSCOPY IN GASTRIC GIST: RETROSPECTIVE PRE-POST COMPARISON ANALYSIS OF SHORT TERM OUTCOMES ON A CONSECUTIVE SERIES OF 95 CASES FROM A TERTIARY REFERRAL CENTRE
Alice Laffi
Favorite
Laffi, Alice
Medical Oncology and Hematology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089, Italy
(
P 117
)
SHOULD REGORAFENIB BE PRESCRIBED AS A CONTINUOUS SCHEDULE AT LEAST IN GASTROINTESTINAL STROMAL TUMORS (GIST)?
Alice Laffi
Favorite
Laffi, Alice
Humanitas Research Hospital
(
P 224
)
THE ROLE OF NEOADJUVANT CHEMOTHERAPY IN RETROPERITONEAL SARCOMA. A CASE-MATCHED ANALYSIS.
Alice Laffi
Favorite
Laffi, Alice
Medical Oncology and Hematology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089, Italy
(
P 247
)
PROGNOSTIC VALUE OF MITOTIC COUNT IN NON-UTERINE LEIOMYOSARCOMAS: A MONOCENTRIC RETROSPECTIVE STUDY.
Alice Laffi
Favorite
Lahmar, Mehdi
Boehringer Ingelheim International GmbH
(
P 314
)
A PHASE II/III, RANDOMIZED, OPEN LABEL, MULTICENTER STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 VS DOXORUBICIN IN THE FIRST-LINE TREATMENT OF PATIENTS WITH DEDIFFERENTIATED LIPOSARCOMA: BRIGHTLINE-1
Mehdi Lahmar
Favorite
Lahr, David
Foghorn Therapeutics
(
P 187
)
PRECLINICAL VALIDATION OF TARGET ENGAGEMENT ASSAYS AND INVESTIGATION OF MECHANISTIC IMPACTS OF FHD-609, A CLINICAL-STAGE BRD9 DEGRADER BEING DEVELOPED FOR THE TREATMENT OF SYNOVIAL SARCOMA
David Lahr
Favorite
Lakhani, Nehal J.
START Midwest
(
P 041
)
UPDATED EFFICACY AND SAFETY OF THE TETRAVALENT DEATH RECEPTOR 5 AGONIST INBRX-109 IN PATIENTS WITH CHONDROSARCOMA: DATA FROM THE PHASE 1 EXPANSION COHORTS
Nehal J. Lakhani
Favorite
(
P 317
)
INBRX-109 IN EWING SARCOMA: PRECLINICAL RATIONALE FOR INITIATION OF A PHASE 1 CHEMOTHERAPY COMBINATION EXPANSION COHORT
Nehal J. Lakhani
Favorite
Lam, Miranda
Dana-Farber Cancer Institute
(
P 214
)
EXPERIENCE OF MANAGEMENT FOR LOCALIZED PARATESTICULAR LIPOSARCOMA: A SINGLE INSTITUTION COHORT
Miranda Lam
Favorite
Lamparski, Lukasz
Medical University of Warsaw
(
P 168
)
SYSTEMIC INFLAMMATION INDEX (SII) AS INDEPENDENT PREDICTIVE FACTOR IN PATIENTS WITH L-SARCOMA TREATED WITH TRABECTEDIN - ANALYSIS OF REAL-WORLD EVIDENCE FROM A REFERENCE CENTER
Lukasz Lamparski
Favorite
Lam, Suk Wai
LUMC
(
P 230
)
CHARACTERIZING TISSUE-BASED CHANGES DURING AND AFTER RADIOTHERAPY IN MYXOID LIPOSARCOMAS IN THE DOREMY TRIAL
Suk Wai Lam
Favorite
(
P 255
)
TRUNCATED FOS REDUCES OSTEOGENIC DIFFERENTIATION CAPACITY IN OSTEOID OSTEOMA AND OSTEOBLASTOMA
Suk Wai Lam
Favorite
Langer, Thorsten
University Hospital for Children and Adolescents, Pediatric Oncology and Hematology, Lübeck, Germany
(
P 040
)
TWO RARE SIDES OF ONE RARE DISEASE: EWING SARCOMA WITH AND AS SECONDARY MALIGNANCIES FROM THE EPIDEMIOLOGICAL AND CLINICAL ANALYSIS OF AN INTERNATIONAL TRIAL REGISTRY
Thorsten Langer
Favorite
Lang, Wenhua
MD Anderson Cancer Center
(
P 013
)
A PHASE 2 TRIAL OF CETUXIMAB FOR PATIENTS WITH LOCALLY ADVANCED/METASTATIC CHORDOMA
Wenhua Lang
Favorite
Lansu, Jules
LUMC
(
P 230
)
CHARACTERIZING TISSUE-BASED CHANGES DURING AND AFTER RADIOTHERAPY IN MYXOID LIPOSARCOMAS IN THE DOREMY TRIAL
Jules Lansu
Favorite
Lanzafame, Helena
Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen
(
P 176
)
FIBROBLAST ACTIVATION PROTEIN ALPHA AS THERANOSTIC TARGET IN SARCOMA
Helena Lanzafame
Favorite
Laskar, Siddharth
Tata Memorial Centre
(
P 03
)
DEMOGRAPHICS, PRACTICE PATTERNS, CHALLENGES AND OUTCOMES OF SYNOVIAL SARCOMA PATIENTS FROM A TERTIARY CARE CENTRE FROM A LARGE LOW-MIDDLE INCOME COUNTRY
Siddharth Laskar
Favorite
(
P 09
)
OUTCOMES, PROGNOSTIC FACTORS AND TREATMENT COMPLIANCE IN OSTEOSARCOMA CASES TREATED WITH AN INDIGENOUS, LOW-COST PROTOCOL, OGS-12, IN A TERTIARY CARE CANCER CENTRE IN INDIA
Siddharth Laskar
Favorite
Lassen, Ulrik N.
Department of Oncology, Rigshospitalet
(
P 107
)
LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT PATIENTS WITH TRK FUSION SARCOMAS
Ulrik N. Lassen
Favorite
Latter, Michelle
Beatson West of Scotland Cancer Centre
(
P 073
)
EVALUATING DISTRESS AND THE PATIENT EXPERIENCE OF SARCOMA PATIENTS IN THE WEST OF SCOTLAND
Michelle Latter
Favorite
Laughlin, Brady
Department of Radiation Oncology, Mayo Clinic
(
P 202
)
LONG-TERM EXPERIENCE WITH INTRAOPERATIVE ELECTRON RADIATION THERAPY BOOST IN EXTREMITY SARCOMA
Brady Laughlin
Favorite
Lau, James YW
Department of Surgery, The Chinese University of Hong Kong
(
P 210
)
A LONGITUDINAL ANALYSIS OF PROGNOSTIC FACTORS IN CHINESE PATIENTS WITH RETROPERITONEAL LIPOSARCOMA
James YW Lau
Favorite
Laurence, Valerie
Institut Curie
(
P 026
)
IS THERE STILL A PLACE FOR BONE MARROW SAMPLING IN VERY HIGH RISK EWING SARCOMA? ROLE OF FDG PET/CT IN THE INITIAL STAGING OF VERY HIGH RISK EWING SARCOMA IN A PROSPECTIVE PHASE II MULTICENTRIC STUDY.
Valerie Laurence
Favorite
Lautz, Timothy
Ann & Robert H Lurie Children's Hospital of Chicago
(
P 155
)
LATE EVENTS OCCURRING AFTER 5 YEARS IN PEDIATRIC RHABDOMYOSARCOMA: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Timothy Lautz
Favorite
Lazar, Alexander
The University of Texas MD Anderson Cancer Center
(
P 013
)
A PHASE 2 TRIAL OF CETUXIMAB FOR PATIENTS WITH LOCALLY ADVANCED/METASTATIC CHORDOMA
Alexander Lazar
Favorite
Lazarides, Alexander
Moffitt Cancer Center
(
P 034
)
REGIONAL ANESTHESIA IMPROVES METASTASIS FREE SURVIVAL AFTER SURGICAL RESECTION OF BONE SARCOMAS
Alexander Lazarides
Favorite
(
P 059
)
SURGICAL MANAGEMENT OF CHONDROSARCOMA OF LONG BONES UTILIZING A PRE-OPERATIVE RADIOLOGIC AGGRESSIVENESS SCORE?
Alexander Lazarides
Favorite
(
P 284
)
HOW DO THE OUTCOMES OF RADIATION ASSOCIATED PELVIC AND SACRAL BONE SARCOMAS COMPARE TO PRIMARY OSTEOSARCOMAS FOLLOWING SURGICAL RESECTION?
Alexander Lazarides
Favorite
Lazarides, Alexander
Duke University School of Medicine
(
P 288
)
LOCKING PLATE AUGMENTATION OF POLYMETHYLMETHACRYLATE-FILLED DISTAL FEMUR DEFECTS
Alexander Lazarides
Favorite
Lazarides, Alexander
Moffitt Cancer Center
(
P 304
)
SURGICAL STAGING OF OSTEOSARCOMA: WHAT IS THE OPTIMAL METHOD FOR PREDICTING LOCAL RECURRENCE?
Alexander Lazarides
Favorite
Lazaro Cabeza, Antonio
Industry
(
P 235
)
ELUCIDATING THE ONCOGENIC EFFECT OF BCOR-ITD IN SARCOMA
Antonio Lazaro Cabeza
Favorite
Lazo de la Vega, Lorena
Dana-Farber Cancer Institute
(
P 239
)
FGFR IS A RELEVANT MOLECULAR TARGET IN PEDIATRIC AND AYA SARCOMAS
Lorena Lazo de la Vega
Favorite
Le Cesne, Axel
Department of Medicine, Gustave Roussy
(
P 102
)
EFFICACY AND SAFETY OF VIMSELTINIB IN TENOSYNOVIAL GIANT CELL TUMOUR: PHASE 2 EXPANSION
Axel Le Cesne
Favorite
(
P 189
)
PROGNOSTIC IMPACT OF NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA-1 EXPRESSION AND HUMAN LEUKOCYTE ANTIGEN SUBTYPES IN METASTATIC SYNOVIAL SARCOMA
Axel Le Cesne
Favorite
(
P 217
)
PLANNED MARGINAL (R1) RESECTION IN PRIMARY RETROPERITONEAL SARCOMAS: RETROSPECTIVE SERIES ON 168 PATIENTS FROM A NATIONAL SPECIALIZED REFERRAL CENTER
Axel Le Cesne
Favorite
Le Pechoux, Cecile
institut gustave roussy
(
P 217
)
PLANNED MARGINAL (R1) RESECTION IN PRIMARY RETROPERITONEAL SARCOMAS: RETROSPECTIVE SERIES ON 168 PATIENTS FROM A NATIONAL SPECIALIZED REFERRAL CENTER
Cecile Le Pechoux
Favorite
Leach, Kent
University of California, Davis/Orthopaedic Surgery and Biomedical Engineering
(
P 175
)
FIBRIN-ALGINATE INTERPENETRATING NETWORK HYDROGELS AS BIOMIMETIC PLATFORMS TO STUDY OSTEOSARCOMA
Kent Leach
Favorite
Leary, Alexandra
CLCC gustave roussy
(
P 048
)
IMMUNE INFILTRATION AS PROGNOSTIC FACTORS IN METASTATIC LEIOMYOSARCOMA
Alexandra Leary
Favorite
Leavey, Patrick
UT Southwestern
(
P 023
)
FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS TREATED WITH SURGERY ON AEWS1031: A REPORT FROM THE CHILDRENS ONCOLOGY GROUP
Patrick Leavey
Favorite
(
P 035
)
RISK FACTORS FOR BONY METASTASES IN PEDIATRIC OSTEOSARCOMA PATIENTS
Patrick Leavey
Favorite
Ledesma, Patricio
Sofpromed
(
P 161
)
PALBOSARC: A PHASE II TRIAL OF PALBOCICLIB IN ADVANCED SARCOMA OVEREXPRESSING CDK4 GENE EXCLUDING DEDIFFERENTIATED LIPOSARCOMA (DD LPS): A STUDY FROM THE SPANISH GROUP FOR RESEARCH ON SARCOMA (GEIS).
Patricio Ledesma
Favorite
Lee, Alexander
The Christie Hospital
(
P 268
)
INITIAL RESULTS OF PHASE 2/3 TRIAL OF AL102 FOR TREATMENT OF DESMOID TUMORS (DT)
Alexander Lee
Favorite
Lee, Che-Jui
Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute
(
P 182
)
NOVEL TISSUE MICROARRAY (TMA) PLATFORM AS A TOOL FOR COLLABORATIVE SOFT TISSUE SARCOMA (STS) RESEARCH
Che-Jui Lee
Favorite
Lee, Elizabeth
Dana-Farber Cancer Institute
(
P 313
)
A PHASE 2, MULTICENTER, OPEN-LABEL BASKET TRIAL OF NAB-SIROLIMUS FOR PATIENTS WITH MALIGNANT SOLID TUMORS HARBORING PATHOGENIC INACTIVATING ALTERATIONS IN TSC1 OR TSC2 GENES (PRECISION I)
Elizabeth Lee
Favorite
Lee, Elizabeth Chun Yong
National Cancer Centre Singapore
(
P 174
)
ESTABLISHMENT AND CHARACTERIZATION OF A PATIENT-DERIVED SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA CELL LINE MODEL
Elizabeth Chun Yong Lee
Favorite
Lee, Jieun
Seoul St. Mary’s Hospital, The Catholic University of Korea
(
P 153
)
IFOSFAMIDE/ETOPOSIDE/CARBOPLATIN REGIMEN AS A POST DOXORUBICIN TREATMENT IN METASTATIC OR RECURRENT SOFT TISSUE SARCOMA
Jieun Lee
Favorite
Lee, Jing Yi
National Cancer Centre Singapore
(
P 174
)
ESTABLISHMENT AND CHARACTERIZATION OF A PATIENT-DERIVED SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA CELL LINE MODEL
Jing Yi Lee
Favorite
Lee, JooHee
Yonsei University College of Medicine
(
P 265
)
DEVELOPMENT OF THERAPEUTIC STRATEGY FOR DESMOID TUMOR WITH NOVEL PATIENT-DERIVED PRECLINICAL MODEL
JooHee Lee
Favorite
Lee, Kyo Won
Samsung Medical Center
(
P 212
)
COMPARISON OF SURGICAL OUTCOMES BETWEEN LEIOMYOSARCOMA OF INFERIOR VENA CAVA AND OTHER LOCATIONS
Kyo Won Lee
Favorite
(
P 215
)
FEASIBILITY AND ADVANTAGE OF PRE-OPERATIVE RADIOTHERAPY IN RETROPERITONEAL SARCOMA
Kyo Won Lee
Favorite
Lee, Linus
Rush University Medical Center
(
P 053
)
PET-CT STAGING AFFECTS TIME TO TREATMENT IN SARCOMA
Linus Lee
Favorite
(
P 062
)
WHAT IS THE CLINICAL IMPACT OF STAGING AND SURVEILLANCE PET-CT SCAN FINDINGS IN PATIENTS WITH BONE AND SOFT TISSUE SARCOMA?
Linus Lee
Favorite
(
P 081
)
MISSING DATA IN THE DEVELOPMENT AND EXTERNAL VALIDATION OF MACHINE LEARNING MODELS FOR SURVIVAL PREDICTION IN SARCOMA
Linus Lee
Favorite
(
P 086
)
RADIOTHERAPY, VOLUME REDUCTION, AND SHORT-TERM SURGICAL OUTCOMES IN THE TREATMENT OF LARGE MYXOID LIPOSARCOMAS
Linus Lee
Favorite
(
P 094
)
TOTAL KNEE ARTHROPLASTY FOR OSTEOARTHRITIS IS UNCOMMON AFTER INTRALESIONAL CURETTAGE IN GIANT CELL TUMOR OF BONE
Linus Lee
Favorite
(
P 206
)
RADIOTHERAPY LEADS TO IMPROVED OVERALL SURVIVAL IN PATIENTS UNDERGOING RESECTION FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Linus Lee
Favorite
(
P 227
)
ASSOCIATION BETWEEN NEUTROPHIL-LYMPHOCYTE RATIO, PLATELET-LYMPHOCYTE RATIO, AND SURVIVAL IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Linus Lee
Favorite
(
P 283
)
HIP ARTHROPLASTY OUTCOMES IN METASTATIC BONE DISEASE
Linus Lee
Favorite
(
P 294
)
PERCUTANEOUS STABILIZATION OF PATHOLOGIC FRACTURES OF THE PELVIS AND SACRUM
Linus Lee
Favorite
Lee, Man Jae
Korea Advanced Institute of Science and Technology(KAIST)
(
P 228
)
CHARACTERIZING ORGANELLES IN MYXOFIBROSARCOMA CELLS USING LABEL-FREE OPTICAL DIFFRACTION TOMOGRAPHY
Man Jae Lee
Favorite
Lee, Stella
University of Pittsburgh Medical Center
(
P 046
)
EVALUATION OF INTRAOPERATIVE TUMOR MARGINS IN SARCOMA WITH FLUORESCENT DYE IMAGING: A PRELIMINARY ANALYSIS OF RESULTS
Stella Lee
Favorite
Lee, Ursula
BC Cancer
(
P 074
)
EWING SARCOMA AND RHABDOMYOSARCOMA PATIENT OUTCOME VARIATIONS BASED ON TREATMENT CENTRE VOLUME
Ursula Lee
Favorite
(
P 165
)
REAL- WORLD EXPERIENCE OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH RECURRENT BONE TUMOURS (BT): A CANSARCC STUDY
Ursula Lee
Favorite
Lee, Young Han
Yonsei University College of Medicine
(
P 265
)
DEVELOPMENT OF THERAPEUTIC STRATEGY FOR DESMOID TUMOR WITH NOVEL PATIENT-DERIVED PRECLINICAL MODEL
Young Han Lee
Favorite
Lefkowitz, Robert
Memorial Sloan Kettering Cancer Center
(
P 134
)
PHASE II STUDY OF RUCAPARIB AND NIVOLUMAB IN PATIENTS WITH LEIOMYOSARCOMA
Robert Lefkowitz
Favorite
Leithner, Andreas
Department of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria
(
P 038
)
TENOSYNOVIAL GIANT CELL TUMOR OBSERVATIONAL PLATFORM PROJECT (TOPP): 2-YEAR OBSERVATIONAL SUB-ANALYSIS OF AGE AND PATIENT-REPORTED OUTCOMES FROM AN EU/US PROSPECTIVE REGISTRY
Andreas Leithner
Favorite
(
P 141
)
TUMOUR-INFILTRATING IMMUNE CELLS IN SOFT TISSUE SARCOMA. IMPACT ON LOCAL RECURRENCE, DISTANT METASTASIS, AND OVERALL SURVIVAL.
Andreas Leithner
Favorite
Leonard, Hugh
EHE Rare Cancer Charity (UK)
(
P 188
)
PRELIMINARY ASSESSMENT OF CIRCULATING INFLAMMATORY CYTOKINES IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE) PATIENTS AND IN AN EHE PATIENT-DERIVED XENOGRAFT BEFORE AND AFTER DOXORUBICIN AND SIROLIMUS
Hugh Leonard
Favorite
Lerman, Daniel
Colorado Limb Consultants
(
P 294
)
PERCUTANEOUS STABILIZATION OF PATHOLOGIC FRACTURES OF THE PELVIS AND SACRUM
Daniel Lerman
Favorite
Leroux, Agnes
Biopathology Department, Institut de Cancérologie de Lorraine
(
P 189
)
PROGNOSTIC IMPACT OF NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA-1 EXPRESSION AND HUMAN LEUKOCYTE ANTIGEN SUBTYPES IN METASTATIC SYNOVIAL SARCOMA
Agnes Leroux
Favorite
Lervat, Cyril
Oscar Lambret
(
P 026
)
IS THERE STILL A PLACE FOR BONE MARROW SAMPLING IN VERY HIGH RISK EWING SARCOMA? ROLE OF FDG PET/CT IN THE INITIAL STAGING OF VERY HIGH RISK EWING SARCOMA IN A PROSPECTIVE PHASE II MULTICENTRIC STUDY.
Cyril Lervat
Favorite
Lesensky, Jan
, Charles University, University Hospital Na Bulovce, Prague
(
P 280
)
COMPLEX SHOULDER EXTRA-ARTICULAR RESECTION AND RECONSTRUCTION: A NOVEL DESIGN
Jan Lesensky
Favorite
Lesluyes, Tom
Francis Crick Institute
(
P 252
)
THE GENOMIC LANDSCAPE OF CLEAR CELL SARCOMA RESEARCH INITIATIVE
Tom Lesluyes
Favorite
Lessnick, Stephen
Abigail Wexner Research Institute at Nationwide Children's Hospital and The Ohio State University
(
P 229
)
CHARACTERIZING THE MICROSATELLITE-BINDING FUNCTION OF EWS-FLI AND ETV6 IN EWING SARCOMA
Stephen Lessnick
Favorite
Leu, Kirsten
Nebraska Cancer
(
P 234
)
DNA DAMAGE RESPONSE PATHWAYS IN SYNOVIAL SARCOMA
Kirsten Leu
Favorite
Levin, Adam
Johns Hopkins
(
P 071
)
DEVELOPMENT OF A COLLABORATIVE SARCOMA REGISTRY: STRATEGIES TO DECREASE PROVIDER BURDEN AND INCREASE ENGAGEMENT
Adam Levin
Favorite
Levine, Brett
Rush University Medical Center
(
P 277
)
BEARING SELECTION IN PROXIMAL FEMORAL REPLACEMENT: A COMPARISON OF CLINICAL OUTCOMES
Brett Levine
Favorite
levy, antonin
Institut Gustave Roussy
(
P 217
)
PLANNED MARGINAL (R1) RESECTION IN PRIMARY RETROPERITONEAL SARCOMAS: RETROSPECTIVE SERIES ON 168 PATIENTS FROM A NATIONAL SPECIALIZED REFERRAL CENTER
antonin levy
Favorite
Levy, Joan
Melanoma Research Alliance
(
P 013
)
A PHASE 2 TRIAL OF CETUXIMAB FOR PATIENTS WITH LOCALLY ADVANCED/METASTATIC CHORDOMA
Joan Levy
Favorite
Lewallen, David
Mayo Clinic
(
P 302
)
SERUM METAL ION CONCENTRATIONS IN THE SETTING OF AN ONCOLOGIC ENDOPROSTHESIS: IS THERE CAUSE FOR CONCERN?
David Lewallen
Favorite
Lewin, Jeremy
Peter MacCallum Cancer Centre
(
P 268
)
INITIAL RESULTS OF PHASE 2/3 TRIAL OF AL102 FOR TREATMENT OF DESMOID TUMORS (DT)
Jeremy Lewin
Favorite
Leyvraz, Serge
Charité – Universitätsmedizin Berlin
(
P 107
)
LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT PATIENTS WITH TRK FUSION SARCOMAS
Serge Leyvraz
Favorite
Liang, Jinrong
Shanghai Sixth People's Hospital
(
P 136
)
PRELIMINARY EFFICACY AND SAFETY OF FAMITINIB PLUS SHR-1701 IN ADVANCED SARCOMA: A SINGLE-CENTER, PHASE 2 TRIAL
Jinrong Liang
Favorite
Liang, Pan
Abbisko Therapeutics
(
P 164
)
PRELIMINARY PHASE 1B RESULTS OF ABSK021 FOR ADVANCED TENOSYNOVIAL GIANT CELL TUMOR: SIGNIFICANT ANTITUMOR ACTIVITY AND FAVOURABLE SAFETY PROFILE
Pan Liang
Favorite
Liang, Yan
Department of Oncology, The First Affiliated Hospital of Nanjing Medical University
(
P 164
)
PRELIMINARY PHASE 1B RESULTS OF ABSK021 FOR ADVANCED TENOSYNOVIAL GIANT CELL TUMOR: SIGNIFICANT ANTITUMOR ACTIVITY AND FAVOURABLE SAFETY PROFILE
Yan Liang
Favorite
Li, Binghao
Department of Orthopedics, The Second Affiliated Hospital of Zhejiang University School of Medicine
(
P 164
)
PRELIMINARY PHASE 1B RESULTS OF ABSK021 FOR ADVANCED TENOSYNOVIAL GIANT CELL TUMOR: SIGNIFICANT ANTITUMOR ACTIVITY AND FAVOURABLE SAFETY PROFILE
Binghao Li
Favorite
Liebner, David
The Ohio State University Comprehensive Cancer Center
(
P 200
)
CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF RADIATION-ASSOCIATED SARCOMAS
David Liebner
Favorite
(
P 259
)
ASSOCIATION BETWEEN AREA DEPRIVATION INDEX AND INITIAL TREATMENT AMONG PATIENTS WITH DESMOID TUMORS
David Liebner
Favorite
Liegl-Atzwanger, Bernadette
Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Medical University of Graz
(
P 141
)
TUMOUR-INFILTRATING IMMUNE CELLS IN SOFT TISSUE SARCOMA. IMPACT ON LOCAL RECURRENCE, DISTANT METASTASIS, AND OVERALL SURVIVAL.
Bernadette Liegl-Atzwanger
Favorite
Lieu, Christopher
University of Colorado
(
P 041
)
UPDATED EFFICACY AND SAFETY OF THE TETRAVALENT DEATH RECEPTOR 5 AGONIST INBRX-109 IN PATIENTS WITH CHONDROSARCOMA: DATA FROM THE PHASE 1 EXPANSION COHORTS
Christopher Lieu
Favorite
Liffers, Sven-Thorsten
Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen
(
P 176
)
FIBROBLAST ACTIVATION PROTEIN ALPHA AS THERANOSTIC TARGET IN SARCOMA
Sven-Thorsten Liffers
Favorite
Li, Li
MD Anderson Cancer Center
(
P 013
)
A PHASE 2 TRIAL OF CETUXIMAB FOR PATIENTS WITH LOCALLY ADVANCED/METASTATIC CHORDOMA
Li Li
Favorite
Lim, Abner
National Cancer Centre Singapore
(
P 174
)
ESTABLISHMENT AND CHARACTERIZATION OF A PATIENT-DERIVED SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA CELL LINE MODEL
Abner Lim
Favorite
Lim, So Hee
Samsung Medical Center
(
P 215
)
FEASIBILITY AND ADVANTAGE OF PRE-OPERATIVE RADIOTHERAPY IN RETROPERITONEAL SARCOMA
So Hee Lim
Favorite
Linardic, Corinne
Duke University School of Medicine
(
P 254
)
THE IMPACT OF MST (HIPPO KINASE) INHIBITION ON CHROMATIN ACCESSIBILITY AND ONCOGENIC PHENOTYPES IN FUSION-POSITIVE RHABDOMYOSARCOMA
Corinne Linardic
Favorite
Linari, Alessandra
Pathology Unit, AOU Città della Salute e della Scienza di Torino
(
P 058
)
SARCOPENIA AS A NEGATIVE PROGNOSTIC FACTOR IN LOCALIZED EXTREMITIES/TRUNK WALL SOFT TISSUE SARCOMAS
Alessandra Linari
Favorite
Lindeman, Neal
Brigham and Women’s Hospital
(
P 239
)
FGFR IS A RELEVANT MOLECULAR TARGET IN PEDIATRIC AND AYA SARCOMAS
Neal Lindeman
Favorite
Lindorff-Larsen, Kresten
University of Copenhagen
(
P 235
)
ELUCIDATING THE ONCOGENIC EFFECT OF BCOR-ITD IN SARCOMA
Kresten Lindorff-Larsen
Favorite
Lindsay, Daniel
Royal National Hospital NHS Trust, UK
(
P 011
)
TACKLE A RARE SARCOMA THROUGH A COLLABORATIVE APPROACH
Daniel Lindsay
Favorite
Lindsay, Daniel
Royal National Orthopaedic Hospital NHS Trust
(
P 252
)
THE GENOMIC LANDSCAPE OF CLEAR CELL SARCOMA RESEARCH INITIATIVE
Daniel Lindsay
Favorite
Lin, Feng
Daiichi Sankyo, Inc.
(
P 066
)
CHARACTERISTICS OF PATIENTS RECEIVING PEXIDARTINIB IN THE REAL-WORLD SETTING: A CROSS-SECTIONAL SURVEY
Feng Lin
Favorite
Lin, Heather
The University of Texas MD Anderson Cancer Center
(
P 013
)
A PHASE 2 TRIAL OF CETUXIMAB FOR PATIENTS WITH LOCALLY ADVANCED/METASTATIC CHORDOMA
Heather Lin
Favorite
Lin, Keldon
Mayo Clinic Alix School of Medicine
(
P 202
)
LONG-TERM EXPERIENCE WITH INTRAOPERATIVE ELECTRON RADIATION THERAPY BOOST IN EXTREMITY SARCOMA
Keldon Lin
Favorite
Link, Madeline
Rush University Medical Center
(
P 018
)
COMPLETE RESPONSE TO MODEST DOSE RADIATION IN OSTEOSARCOMA METASTASIS IN TWO PATIENTS WITH LI-FRAUMENI SYNDROME
Madeline Link
Favorite
(
P 032
)
PLEURAL RELAPSE OF OSTEOSARCOMA AFTER TALC PLEURODESIS
Madeline Link
Favorite
Lipka, Daniel
National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center
(
P 231
)
COMPREHENSIVE MOLECULAR PROFILING OF FOLLICULAR DENDRITIC CELL SARCOMA
Daniel Lipka
Favorite
Liu, Kunpeng
Department of Anesthesiology, Peking University International Hospital
(
P 211
)
ANESTHESIA MANAGEMENTS AND POSTOPERATIVE MORTALITIES IN RETROPERITONEAL SARCOMA PATIENTS EXPERIENCING MASSIVE BLOOD TRANSFUSION DURING SURGERIES
Kunpeng Liu
Favorite
Liu, Ninning
Wyss Institute for Biologically Inspired Engineering, Harvard University
(
P 099
)
CONCURRENT INHIBITION OF CDK2 ADDS TO THE ANTI-TUMOR ACTIVITY OF CDK4/6 INHIBITION IN GIST
Ninning Liu
Favorite
Liu, Tianshu
Zhongshan Hospital, Fudan University
(
P 107
)
LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT PATIENTS WITH TRK FUSION SARCOMAS
Tianshu Liu
Favorite
Liverani, Chiara
Osteoncology Unit, Bioscience Laboratory, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, Italy
(
P 195
)
THE STRATEGIC ROLE OF 3D CULTURE SYSTEMS AND ZEBRAFISH NEAR-PATIENTS PRECLINICAL PLATFORMS AS PREDICTIVE TOOLS OF CHEMOTHERAPY RESPONSE FOR SARCOMA
Chiara Liverani
Favorite
(
P 250
)
SYSTEMIC INFLAMMATORY INDICES IN SECOND LINE SOFT TISSUE SARCOMAS PATIENTS: FOCUS ON LYMPHOCYTE/MONOCYTE RATIO AND TRABECTEDIN ACTIVITY
Chiara Liverani
Favorite
Livingston, J. Andrew
The University of Texas MD Anderson Cancer Center
(
P 013
)
A PHASE 2 TRIAL OF CETUXIMAB FOR PATIENTS WITH LOCALLY ADVANCED/METASTATIC CHORDOMA
J. Andrew Livingston
Favorite
(
P 144
)
A PHASE 1/2 DOSE ESCALATION/EXPANSION STUDY OF ZN-C3 PLUS GEMCITABINE IN RELAPSED/REFRACTORY OSTEOSARCOMA
J. Andrew Livingston
Favorite
Livingston, Michael
Atrium Health/Levine Cancer Institute
(
P 261
)
CLINICAL FEATURES AND TREATMENT OUTCOMES OF PATIENTS WITH DESMOID TUMORS: A LARGE SINGLE INSTITUTION RETROSPECTIVE SERIES
Michael Livingston
Favorite
Li, Wenjie
Department of Retroperitoneal Tumor Surgery, Peking University International Hospital
(
P 222
)
SURGICAL RESECTION OF ABDOMINOPELVIC AGGRESSIVE ANGIOMYXOMA: A RETROSPECTIVE REVIEW OF 12 CONSECUTIVE CASES
Wenjie Li
Favorite
Li, William
UPMC Department of Orthopaedic Surgery
(
P 025
)
INCREASED ALDH1A1 AND ATOX1 GENE EXPRESSION AND COPPER LEVELS IN CANINE OSTEOSARCOMA PATIENTS
William Li
Favorite
(
P 046
)
EVALUATION OF INTRAOPERATIVE TUMOR MARGINS IN SARCOMA WITH FLUORESCENT DYE IMAGING: A PRELIMINARY ANALYSIS OF RESULTS
William Li
Favorite
(
P 087
)
RATING THE EFFICACY OF DIAGNOSTIC IMAGING STUDIES PERFORMED FOR THE WORK-UP OF MUSCULOSKELETAL MASSES
William Li
Favorite
Li, Yuan
Peking University People’s Hospital
(
P 021
)
DISTINCT GENOMIC FEATURES BETWEEN OSTEOSARCOMAS FIRSTLY METASTASING TO BONE AND TO LUNG
Yuan Li
Favorite
Li, Yvonne
Dana-Farber Cancer Institute
(
P 239
)
FGFR IS A RELEVANT MOLECULAR TARGET IN PEDIATRIC AND AYA SARCOMAS
Yvonne Li
Favorite
Li, Zhimei
National Cancer Centre Singapore
(
P 174
)
ESTABLISHMENT AND CHARACTERIZATION OF A PATIENT-DERIVED SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA CELL LINE MODEL
Zhimei Li
Favorite
Lobbardi, Riadh
C4 Therapeutics
(
P 312
)
A PHASE 1/2 STUDY OF CFT8634, A NOVEL BIFUNCTIONAL DEGRADATION ACTIVATING COMPOUND (BIDAC) DEGRADER OF BRD9, IN SYNOVIAL SARCOMA AND SMARCB1-NULL TUMORS
Riadh Lobbardi
Favorite
Loggers, Elizabeth
University of Washington/Fred Hutch Cancer Center
(
P 063
)
A RETROSPECTIVE COHORT ANALYSIS EVALUATING THE NATURAL HISTORY AND CHARACTERISTICS OF ANGIOSARCOMAS OF THE BREAST
Elizabeth Loggers
Favorite
Loh, Jui Wan
National Cancer Centre Singapore
(
P 174
)
ESTABLISHMENT AND CHARACTERIZATION OF A PATIENT-DERIVED SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA CELL LINE MODEL
Jui Wan Loh
Favorite
Longhi, Alessandra
Rizzoli Orthopedic Institute IRCCS
(
P 031
)
PAZOPANIB IN ADVANCED BONE SARCOMA: A RETROSPECTIVE ANALYSIS OF RIZZOLI ORTHOPEDIC INSTITUTE
Alessandra Longhi
Favorite
(
P 148
)
ANALYSIS OF REECUR TRIAL DATA TO EVALUATE POTENTIAL PROGNOSTIC FACTORS IN RECURRENT AND PRIMARY REFRACTORY EWING SARCOMA (RR-ES)
Alessandra Longhi
Favorite
Longo-Muñoz, Federico
Department of Medical Oncology, Ramón y Cajal University Hospital
(
P 157
)
MOLECULAR SCREENING OF ADVANCED SARCOMAS THROUGH NEXT-GENERATION SEQUENCING IN A TERTIARY UNIVERSITY HOSPITAL
Federico Longo-Muñoz
Favorite
Loong, Herbert
The Chinese University of Hong Kong
(
P 186
)
PRECLINICAL STUDY OF DOXORUBICIN IN COMBINATION WITH PANOBINOSTAT IN XENOGRAFT MICE MODELS OF SOFT TISSUE SARCOMAS
Herbert Loong
Favorite
(
P 210
)
A LONGITUDINAL ANALYSIS OF PROGNOSTIC FACTORS IN CHINESE PATIENTS WITH RETROPERITONEAL LIPOSARCOMA
Herbert Loong
Favorite
López Alvarez, María
IBIS
(
P 113
)
PROGNOSTIC AND/OR PREDICTIVE VALUE OF EXON 11 MUTATIONS IN TUMOR RESPONSE TO IMATINIB IN METASTATIC GASTROINTESTINAL STROMAL TUMOR :RETROSPECTIVE ANALYSIS OF A MULTICENTRIC NATIONAL REGISTRY
María López Alvarez
Favorite
López Guerrero, Jose Antonio
Instituto Valenciano Oncología
(
P 113
)
PROGNOSTIC AND/OR PREDICTIVE VALUE OF EXON 11 MUTATIONS IN TUMOR RESPONSE TO IMATINIB IN METASTATIC GASTROINTESTINAL STROMAL TUMOR :RETROSPECTIVE ANALYSIS OF A MULTICENTRIC NATIONAL REGISTRY
Jose Antonio López Guerrero
Favorite
Lopez Martin, Jose Antonio
HU Doce de Octubre
(
P 161
)
PALBOSARC: A PHASE II TRIAL OF PALBOCICLIB IN ADVANCED SARCOMA OVEREXPRESSING CDK4 GENE EXCLUDING DEDIFFERENTIATED LIPOSARCOMA (DD LPS): A STUDY FROM THE SPANISH GROUP FOR RESEARCH ON SARCOMA (GEIS).
Jose Antonio Lopez Martin
Favorite
Lopez Nunez, Oscar
Cincinnati Children's Hospital Medical Center
(
P 118
)
SOMATOSTATIN RECEPTOR TYPE 2 EXPRESSION IN SARCOMA
Oscar Lopez Nunez
Favorite
Lopez-Aguiar, Alexandra
The Ohio State University Comprehensive Cancer Center
(
P 259
)
ASSOCIATION BETWEEN AREA DEPRIVATION INDEX AND INITIAL TREATMENT AMONG PATIENTS WITH DESMOID TUMORS
Alexandra Lopez-Aguiar
Favorite
Lopez-Bastida, Julio
University Castilla-La Mancha, Talavera de la Reina, Spain
(
P 038
)
TENOSYNOVIAL GIANT CELL TUMOR OBSERVATIONAL PLATFORM PROJECT (TOPP): 2-YEAR OBSERVATIONAL SUB-ANALYSIS OF AGE AND PATIENT-REPORTED OUTCOMES FROM AN EU/US PROSPECTIVE REGISTRY
Julio Lopez-Bastida
Favorite
Lopez, David
HCU VIRGEN ARRIXACA
(
P 318
)
NEOADJUVANT CHEMORADIOTHERAPY IN ADVANCED SOFT TISSUE SARCOMA. UPDATED NASAR STUDY
David Lopez
Favorite
Lopez, Fernando
Hospital clínico universitario
(
P 119
)
SURGICAL MANAGEMENT OF GASTROINTESTINAL STROMAL TUMOURS SARCOMATOSIS (GISTOSIS). A RETROSPECTIVE MULTI-INSTITUTIONAL STUDY
Fernando Lopez
Favorite
Lopez-Garcia, Pablo
Center for Biomarker Research in Medicine (CBmed)
(
P 141
)
TUMOUR-INFILTRATING IMMUNE CELLS IN SOFT TISSUE SARCOMA. IMPACT ON LOCAL RECURRENCE, DISTANT METASTASIS, AND OVERALL SURVIVAL.
Pablo Lopez-Garcia
Favorite
Lopez-Hisijos, Nicolas
Rush University Medical Center
(
P 086
)
RADIOTHERAPY, VOLUME REDUCTION, AND SHORT-TERM SURGICAL OUTCOMES IN THE TREATMENT OF LARGE MYXOID LIPOSARCOMAS
Nicolas Lopez-Hisijos
Favorite
Lopez-Pousa, Antonio
Hospital de la Santa Creu I Sant Pau, Barcelona, Spain
(
P 038
)
TENOSYNOVIAL GIANT CELL TUMOR OBSERVATIONAL PLATFORM PROJECT (TOPP): 2-YEAR OBSERVATIONAL SUB-ANALYSIS OF AGE AND PATIENT-REPORTED OUTCOMES FROM AN EU/US PROSPECTIVE REGISTRY
Antonio Lopez-Pousa
Favorite
(
P 113
)
PROGNOSTIC AND/OR PREDICTIVE VALUE OF EXON 11 MUTATIONS IN TUMOR RESPONSE TO IMATINIB IN METASTATIC GASTROINTESTINAL STROMAL TUMOR :RETROSPECTIVE ANALYSIS OF A MULTICENTRIC NATIONAL REGISTRY
Antonio Lopez-Pousa
Favorite
(
P 135
)
PREDICTIVE VALUE OF ISG15 AND PPAP2B IN SOLITARY FIBROUS TUMOR TREATED WITH SUNITINIB AND NIVOLUMAB: A CORRELATIVE STUDY FROM IMMUNOSARC, A SPANISH GROUP FOR RESEARCH ON SARCOMA (GEIS) PHASE II TRIAL
Antonio Lopez-Pousa
Favorite
(
P 161
)
PALBOSARC: A PHASE II TRIAL OF PALBOCICLIB IN ADVANCED SARCOMA OVEREXPRESSING CDK4 GENE EXCLUDING DEDIFFERENTIATED LIPOSARCOMA (DD LPS): A STUDY FROM THE SPANISH GROUP FOR RESEARCH ON SARCOMA (GEIS).
Antonio Lopez-Pousa
Favorite
Lopez-Sanchez, Andres
HCU VIRGEN ARRIXACA
(
P 318
)
NEOADJUVANT CHEMORADIOTHERAPY IN ADVANCED SOFT TISSUE SARCOMA. UPDATED NASAR STUDY
Andres Lopez-Sanchez
Favorite
LOTTIN, Marine
CHU Amiens
(
P 080
)
INTRACRANIAL SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA MANAGEMENT: A FRENCH MULTICENTRE RETROSPECTIVE STUDY
Marine LOTTIN
Favorite
Lowy, Israel
Regeneron Pharmaceuticals
(
P 131
)
MUCIN 16 (CANCER ANTIGEN 125) EXPRESSION IN EPITHELIOID SARCOMA LEADS TO SINGLE-PATIENT STUDY WITH BISPECIFIC T-CELL ENGAGER UBAMATAMAB (MUCIN16-CD3): A BENCH-TO-BEDSIDE EXPERIENCE
Israel Lowy
Favorite
Lozano, Pablo
Hospital general universitario Gregorio marañon
(
P 119
)
SURGICAL MANAGEMENT OF GASTROINTESTINAL STROMAL TUMOURS SARCOMATOSIS (GISTOSIS). A RETROSPECTIVE MULTI-INSTITUTIONAL STUDY
Pablo Lozano
Favorite
Lucarelli, Anthony
Boehringer Ingelheim Pharmaceuticals Inc
(
P 314
)
A PHASE II/III, RANDOMIZED, OPEN LABEL, MULTICENTER STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 VS DOXORUBICIN IN THE FIRST-LINE TREATMENT OF PATIENTS WITH DEDIFFERENTIATED LIPOSARCOMA: BRIGHTLINE-1
Anthony Lucarelli
Favorite
Lucatelli, Maria Victoria
Pharmacology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089, Italy
(
P 117
)
SHOULD REGORAFENIB BE PRESCRIBED AS A CONTINUOUS SCHEDULE AT LEAST IN GASTROINTESTINAL STROMAL TUMORS (GIST)?
Maria Victoria Lucatelli
Favorite
Lu, Diana
(
P 229
)
CHARACTERIZING THE MICROSATELLITE-BINDING FUNCTION OF EWS-FLI AND ETV6 IN EWING SARCOMA
Diana Lu
Favorite
Lu, Hezhe
Chinese Academy of Sciences
(
P 021
)
DISTINCT GENOMIC FEATURES BETWEEN OSTEOSARCOMAS FIRSTLY METASTASING TO BONE AND TO LUNG
Hezhe Lu
Favorite
Luksch, Roberto
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
(
P 148
)
ANALYSIS OF REECUR TRIAL DATA TO EVALUATE POTENTIAL PROGNOSTIC FACTORS IN RECURRENT AND PRIMARY REFRACTORY EWING SARCOMA (RR-ES)
Roberto Luksch
Favorite
Luli, Saimir
Preclinical In Vivo Imaging, Translational and Clinical Research Institute, Newcastle University, UK
(
P 172
)
DEVELOPMENT OF A TARGETED DUAL-MODALITY RADIOIMMUNOCONJUGATE FOR IMAGE GUIDED SARCOMA SURGERY
Saimir Luli
Favorite
Lundberg, Meijun Z.
Brigham and Women’s Hospital
(
P 099
)
CONCURRENT INHIBITION OF CDK2 ADDS TO THE ANTI-TUMOR ACTIVITY OF CDK4/6 INHIBITION IN GIST
Meijun Z. Lundberg
Favorite
Luo, Baiwen
The N.1 Institute for Health, National University of Singapore
(
P 196
)
THERAPEUTIC VULNERABILITY AND RESISTANCE DURING PROGRESSION OF AN AGGRESSIVE SOLITARY FIBROUS TUMOUR
Baiwen Luo
Favorite
LUO, CHENGHUA
Department of Retroperitoneal Tumor Surgery, Peking University International Hospital
(
P 211
)
ANESTHESIA MANAGEMENTS AND POSTOPERATIVE MORTALITIES IN RETROPERITONEAL SARCOMA PATIENTS EXPERIENCING MASSIVE BLOOD TRANSFUSION DURING SURGERIES
CHENGHUA LUO
Favorite
(
P 213
)
EPITHELIOID INFLAMMATORY MYOFIBROBLASTIC SARCOMA WITH LEUKEMOID REACTION
CHENGHUA LUO
Favorite
(
P 216
)
LONG TERM SURVIVAL AND PROGNOSTIC FACTORS IN PATIENTS WITH PRIMARY RETROPERITONEAL LEIOMYOSARCOMA UNDERGOING SURGERIES: REAL WORLD DATA FROM A CHINA RETROPERITONEAL SARCOMA REFERRAL CENTER
CHENGHUA LUO
Favorite
(
P 222
)
SURGICAL RESECTION OF ABDOMINOPELVIC AGGRESSIVE ANGIOMYXOMA: A RETROSPECTIVE REVIEW OF 12 CONSECUTIVE CASES
CHENGHUA LUO
Favorite
(
P 223
)
SURGICAL RESECTION OF RETROPERITONEAL LEIOMYOSARCOMA IN 97 CONSECUTIVE PATIENTS - EXPERIENCES FROM A CHINA RETROPERITONEAL SARCOMA REFERRAL CENTER
CHENGHUA LUO
Favorite
Luo, Kun
Shanghai OrigiMed Co., Ltd
(
P 021
)
DISTINCT GENOMIC FEATURES BETWEEN OSTEOSARCOMAS FIRSTLY METASTASING TO BONE AND TO LUNG
Kun Luo
Favorite
Luo, Meijuan
Department of Pharmacy, The First Affiliated Hospital of Sun Yat-sen University
(
P 111
)
PLASMA CONCENTRATION MONITORING AND PERSONALIZED DESENSITIZATION THERAPY IN PATIENTS OF GASTROINTESTINAL STROMAL TUMORS WITH IMATINIB-ASSOCIATED SKIN RASH
Meijuan Luo
Favorite
Luo, Yi
Department of Orthopedics, West China Hospital, Sichuan University
(
P 164
)
PRELIMINARY PHASE 1B RESULTS OF ABSK021 FOR ADVANCED TENOSYNOVIAL GIANT CELL TUMOR: SIGNIFICANT ANTITUMOR ACTIVITY AND FAVOURABLE SAFETY PROFILE
Yi Luo
Favorite
Luque-Caro, Natalia
Hospital Universitario de Jaén
(
P 083
)
PERFORMANCE OF THE MESENCHYMAL TUMOR COMMITTEE IN A SMALL HOSPITAL IN SOUTHERN SPAIN
Natalia Luque-Caro
Favorite
Lydon, Nick
IDRx, Inc
(
P 316
)
FIRST-IN-HUMAN PHASE 1/1B STUDY OF IDRX-42, A NOVEL ORAL TYROSINE KINASE KIT INHIBITOR, IN PARTICIPANTS WITH METASTATIC AND/OR UNRESECTABLE GASTROINTESTINAL STROMAL TUMORS
Nick Lydon
Favorite
Lynch, Kathleen
New York University
(
P 04
)
EXPERT PANEL REVIEW OF THE PRO-AYA: PARTIENT-REPORTED OUTCOMES FOR ADOLESCENTS AND YOUNG ADULTS WITH CANCER
Kathleen Lynch
Favorite
Back to Top
